Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSA | P10619 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 3/20 | 0.31 |
| ▸ | CES1 | P23141 | 3/20 | 0.31 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.30 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15441401 | 0.80 | CTSA (0.38) | CTSACES2CES1KCNQ3KCNQ2 | |
| SCHEMBL3792291 | 0.80 | ALDH1A1 (0.41) | CTSA | |
| SCHEMBL18498680 | 0.78 | CTSA (0.40) | CTSACES2CES1 | |
| SCHEMBL18817829 | 0.78 | CTSA (0.38) | CTSACES2CES1KCNQ3KCNQ2 | |
| SCHEMBL18784144 | 0.78 | ALDH1A1 (0.39) | CTSACES2CES1KCNQ3KCNQ2 | |
| SCHEMBL23631780 | 0.78 | IDO1 (0.41) | CTSA | |
| SCHEMBL31141502 | 0.78 | PTPN1 (0.42) | CTSA | |
| SCHEMBL18498755 | 0.78 | PTPN1 (0.42) | CTSA | |
| SCHEMBL15093907 | 0.74 | NPSR1 (0.50) | CTSA | |
| SCHEMBL23067217 | 0.74 | CTSA (0.47) | CTSA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3162795-B1 | METHOD FOR MANUFACTURING 3-(ALKYL SULFONYL)PYRIDINE-2-CARBOXYLIC ACID | SUMITOMO CHEMICAL CO (JP) | 2019-07-31 | — | — | EP | disclosed |
| CN-106660958-B | The manufacturing method of 3- (alkyl sulphonyl) pyridine-2-carboxylic acids | 住友化学株式会社 | 2019-04-12 | — | — | CN | disclosed |
| US-9815786-B2 | Method for manufacturing 3-(alkylsulfonyl)pyridine-2-carboxylic acid | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-11-14 | — | — | US | disclosed |
| US-20170129859-A1 | METHOD FOR MANUFACTURING 3-(ALKYLSULFONYL)PYRIDINE-2-CARBOXYLIC ACID | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-05-11 | — | — | US | disclosed |
| EP-3162795-A1 | METHOD FOR MANUFACTURING 3-(ALKYL SULFONYL)PYRIDINE-2-CARBOXYLIC ACID | Sumitomo Chemical Company, Limited (JP) | 2017-05-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170129859-A1 | METHOD FOR MANUFACTURING 3-(ALKYLSULFONYL)PYRIDINE-2-CARBOXYLIC ACID | STS, SRM, CERS2 | CTSA 3684/4885CES2 836/4885CES1 2082/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.